Breast cancer in reproductive age. The new plaque or just myth?
Tài liệu tham khảo
2000
Ries, 2008
Hickey, 2009, Breast cancer in young women and its impact on reproductive function, Hum Reprod Update, 15, 323, 10.1093/humupd/dmn064
Kollias, 1997, Early-onset breast cancer: histopathological and prognostic consideration, Br J Cancer, 75, 1318, 10.1038/bjc.1997.223
Shannon, 2003, Breast cancer in adolescents and young women, Eur J Cancer, 39, 2632, 10.1016/S0959-8049(03)00669-5
Walker, 1996, Breast carcinomas occurring in young women are different, Br J Cancer, 74, 1796, 10.1038/bjc.1996.632
Winchester, 1996, The national cancer data base report on breast cancer characteristics and outcome in relation to age, Cancer, 78, 1838, 10.1002/(SICI)1097-0142(19961015)78:8<1838::AID-CNCR27>3.0.CO;2-Y
Chung, 1996, Younger women with breast cancer have a poorer prognosis than older women, Cancer, 77, 97, 10.1002/(SICI)1097-0142(19960101)77:1<97::AID-CNCR16>3.0.CO;2-3
Adami, 1986, The relationship between survival and age at diagnosis in breast cancer, NEJM, 315, 559, 10.1056/NEJM198608283150906
Saphner, 1996, Annual hazard rates of recurrence for breast cancer after primary therapy, J Clin Oncol, 14, 2738, 10.1200/JCO.1996.14.10.2738
Gajdos, 2000, Stage 0 to stage III breast cancer in young 12women, J Am Coll Surg, 190, 523, 10.1016/S1072-7515(00)00257-X
Anders, 2008, Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression, J Clin Oncol, 26, 3324, 10.1200/JCO.2007.14.2471
Colleoni, 2002, Very young women (<35 years) with operable breast cancer: features of disease at presentation, Ann Oncol, 13, 273, 10.1093/annonc/mdf039
Ahn, 2007, Poor outcome of hormone receptor positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea-A report from the Korean breast cancer society, J Clin Oncol, 25, 2360, 10.1200/JCO.2006.10.3754
Bertheau, 1998, C-erbB-2, p53 and nm23 gene product expression in breast cancer in young women: immunohistochemical analysis and clinic pathologic correlation, Hum Pathol, 29, 323, 10.1016/S0046-8177(98)90111-3
Avis, 2004, Psychosocial problems among younger women with breast cancer, Psycho-Oncology, 2004, 295, 10.1002/pon.744
Di Nubila, 2006, Radiologic features and pathological-biological correlations in 348 women with breast cancer under 35 years old, Breast, 15, 744, 10.1016/j.breast.2006.02.006
Weber-Mangal, 2003, Breast cancer in young women (35 years): genomic aberrations detected by comparative genomic hybridization, Int J Cancer, 107, 583, 10.1002/ijc.11460
Aebi, 2000, Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?, Lancet, 355, 1869, 10.1016/S0140-6736(00)02292-3
Kaklamani, 2006, A genetic signature can predict prognosis and response to therapy in breast cancer: oncotype DX, Expert Rev Mol Diagn, 6, 803, 10.1586/14737159.6.6.803
Klauber-DeMore, 2005, Tumor biology of breast cancer in young women, Breast Dis, 23, 9, 10.3233/BD-2006-23103
Bentzon, 2008, Prognostic effect of estrogen receptor status across age in primary breast cancer, Int J Cancer, 122, 1089, 10.1002/ijc.22892
Rakha, 2008, Basal-like breast cancer: a critical review, J Clin Oncol, 26, 2568, 10.1200/JCO.2007.13.1748
van der Hage, 2006, Impact of established prognostic factors in early-stage breast cancer in very young breast cancer patients: a translational research project using pooled datasets derived from 4 EORTC breast group trials. Abstract 6024, Breast Cancer Res Treat, 100, S264
Bollet, 2007, Age remains the first prognostic factor for loco-regional recurrence in young (<40 years) women treated with breast conserving surgery first, Radiother Oncol, 82, 272, 10.1016/j.radonc.2007.01.001
MacKarem, 2001, The effectiveness of the Gail Model in estimating risk for development of breast cancer in women under 40 years of age, Breast J, 7, 34, 10.1046/j.1524-4741.2001.007001034.x
Jensen, 2003, Stage and survival in breast cancer patients in screened and non-screened Danish and Swedish populations, Acta Oncol, 42, 701, 10.1080/02841860310010556
Ghafouri, 2006, Modified triple test score (MTTS) for evaluation of palpable breast masses in women under age 40, MJIRI, 20, 115
Harris, 1989, Indications for breast imaging in women under age 35 years, Radiology, 172, 445, 10.1148/radiology.172.2.2664867
Houssami, 2003, Sydney breast imaging accuracy study: comparative sensitivity and specificity of mammography and sonography in young women with symptoms, Am J Roentgenol, 180, 935, 10.2214/ajr.180.4.1800935
Murrow, 1998, The evaluation of breast masses in women younger than 40 years of age, Surgery, 124, 634, 10.1067/msy.1998.91485
Brinton, 2008, Recent trends in breast cancer among younger women in the United States, J Natl Cancer Inst, 100, 1643, 10.1093/jnci/djn344
Kalager, 2010, Effect of screening mammography on breast-cancer mortality in Norway, N Engl J Med, 363, 1203, 10.1056/NEJMoa1000727
Pisano, 2005, Diagnostic performance of digital versus film mammography for breast cancer screening, NEJM, 353, 1773, 10.1056/NEJMoa052911
Lehman, 2007, ACRIN trial 6667 investigators group. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer, NEJM, 356, 1295, 10.1056/NEJMoa065447
Wesolowski, 2010, A young woman with a breast mass: what every internist should know, Cleve Clin J Med, 77, 537, 10.3949/ccjm.77a.09095
Schell, 2009, Role of breast MRI in the preoperative evaluation of patients with newly diagnosed breast cancer, AJR Am J Roentgenol, 192, 1438, 10.2214/AJR.08.1551
Plevritis, 2006, Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging, JAMA, 295, 2374, 10.1001/jama.295.20.2374
Smith, 2004, An overview of the status of screening technology for breast cancer, Ann Oncol, 15, 18, 10.1093/annonc/mdh653
Reiser, 2006, Computerized mass detection for digital breast tomosynthesis directly from the projection images, Med Phys, 33, 482, 10.1118/1.2163390
Molina, 2005, Tumor markers in breast cancer-European Group on tumor markers recommendations, Tumor Biol, 26, 281, 10.1159/000089260
White, 2008, American College of Radiology appropriateness criteria on conservative surgery and radiation: stages I and II breast carcinoma, J Am Coll Radiol, 5, 701, 10.1016/j.jacr.2008.02.026
Schwartz, 2006, Consensus conference on breast conservation, Milan, Italy, April 28–May 1, 2005, Breast J, 12, 398, 10.1111/j.1075-122X.2006.00292.x
Clarke, 2005, Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials, Lancet, 366, 2087, 10.1016/S0140-6736(05)67887-7
Sharma, 2011, Management of local-regional recurrence following Immediate breast reconstruction in patients with early breast cancer treated without Postmastectomy radiotherapy, Plast Reconstr Surg, 127, 1763, 10.1097/PRS.0b013e31820cf24c
Xu, 2009, Bipedicle deep inferior epigastric perforator flap for unilateral breast reconstruction: seven years’ experience, Plast Reconstr Surg, 124, 1797, 10.1097/PRS.0b013e3181bf81cf
Krag, 2007, Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial, Lancet Oncol, 8, 881, 10.1016/S1470-2045(07)70278-4
Giuliano, 2011, Axillary dissection vs No axillary dissection in women with invasive breast cancer and sentinel node metastasis, JAMA, 305, 569, 10.1001/jama.2011.90
Weaver, 2011, Effect of occult metastases on survival in node-negative breast cancer, N Engl J Med, 364, 412, 10.1056/NEJMoa1008108
Stamatakos, 2010, Sentinel lymph node biopsy in breast cancer: a systematic review, Onkologie, 33, 121, 10.1159/000277142
Dahabreh, 2010, CYP2D6 testing to predict response to tamoxifen in women with breast cancer: Pharmacogenomic, PLoS Curr, 2, 10.1371/currents.RRN1176
Cancello, 2008, Continuing trastuzumab beyond disease progression: outcomes analysis in patients with metastatic breast cancer, Breast Cancer Res, 10, R60, 10.1186/bcr2119
Swain, 2010, Longer therapy, Iatrogenic amenorrhea, and survival in early breast cancer, N Engl J Med, 362, 2053, 10.1056/NEJMoa0909638
Walshe, 2006, Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer, J Clin Oncol, 24, 5769, 10.1200/JCO.2006.07.2793
Cleator, 2009, 2009 update on the treatment of patients with hormone receptor-positive breast cancer, Clin Breast Cancer, 9, S6, 10.3816/CBC.2009.s.001
Zhou, 2010, Incidence of chemotherapy-induced amenorrhea associated with epirubicin, docetaxel and navelbine in younger breast cancer patients, BMC Cancer, 10, 281, 10.1186/1471-2407-10-281
Gelber, 2001, Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancer, J Clin Oncol, 19, 1671, 10.1200/JCO.2001.19.6.1671
Knobf, 2006, The influence of endocrine effects of adjuvant therapy on quality of life outcomes in younger breast cancer survivors, Oncologist, 11, 96, 10.1634/theoncologist.11-2-96
Calhoun, 2005, The effect of pregnancy on survival in women with a history of breast cancer, Breast Dis, 23, 81, 10.3233/BD-2006-23111
Azim, 2008, Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study, J Clin Oncol, 26, 2630, 10.1200/JCO.2007.14.8700
Lee, 2010, Fertility and reproductive considerations in premenopausal patients with breast cancer, Cancer Control, 17, 162, 10.1177/107327481001700304
Michels, 2007, Induced and spontaneous abortion and incidence of breast cancer among young women, Arch Intern Med, 167, 814, 10.1001/archinte.167.8.814
Sonmezer, 2006, Fertility preservation in young women undergoing breast cancer therapy, Oncologist, 11, 422, 10.1634/theoncologist.11-5-422
Kolb, 2002, Comparison of the performance of screening mammography, physical exam and breast ultrasound and analysis of features that influence them: an analysis of 27,825 patient evaluations, Radiology, 225, 165, 10.1148/radiol.2251011667